WWiKY Biosciences Inc. (WWiKY) shares a passion for a cancer-free future. We are committed to developing a spectrum of cancer theranostics (both therapy and diagnostics) that strike at the core of treatment failure. Our mission is to exploit hypoxia, a condition that leads to metastatic progression and therapy resistance in cancer, to identify eligible patients (imaging) and then treat them with the same or similar drug, thus providing a personalized approach to the management of drug-resistant and radiation-resistant hypoxic cells that are commonplace in most solid tumors, and which are responsible for the aggressive, treatment-resistant nature of hypoxic tumors.